Home/Pipeline/Nu.Q® Discover

Nu.Q® Discover

Research assay for H3.1 epigenetic profiling

AvailableActive

Key Facts

Indication
Research assay for H3.1 epigenetic profiling
Phase
Available
Status
Active
Company

About VolitionRx

VolitionRx delivers early‑diagnostic blood tests using nucleosome epigenetics for oncology, sepsis and related diseases.

View full company profile